Unlike the case with thrombosis, prognostic models for survival and leukemic transformation
(LT) in essential thrombocythemia (ET) are not available. Among 605 patients with ET seen …

Background Essential thrombocythemia is a chronic myeloproliferative disorder; patients
with this disorder have a propensity to develop thrombosis, myelofibrosis, and leukemia …

A total of 187 consecutive patients with essential thrombocythemia (ET) were diagnosed and
followed by our Hematology Department in the period October 1980–November 1994. The …

Established risk factors for thrombosis in essential thrombocythemia (ET) include age (≥ 60
years) and previous vascular events. Recently, also leukocytosis has been proposed in risk …

A working diagnosis of essential thrombocythemia (ET) is made in the presence of
nonreactive thrombocytosis and after the exclusion of another chronic myeloid disorder that …

To identify prognostic factors affecting thrombosis‐free survival (TFS) and overall survival
(OS), we report the experience of a Regional cooperative group in a real‐life cohort of 1,144 …

Purpose Established risk factors for thrombosis in essential thrombocythemia (ET) include
age and previous vascular events. We aimed to refine this risk stratification by adding …

Leukocytes contribute to the pathogenesis of thrombosis in essential thrombocythemia (ET)
through recently discovered mechanisms of activation and interaction with platelets and …

OBJECTIVE To describe the long-term natural history of essential thrombocythemia (ET) in
terms of life expectancy, risk of disease transformation into a more aggressive myeloid …

In an international collaborative study, a central histologic review identified 891 patients with
essential thrombocythemia, strictly defined by World Health Organization criteria. After a …